These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17170039)

  • 1. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA; Owens DK; Sanders GD
    Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analyses alongside randomised clinical trials.
    Gray AM
    Clin Trials; 2006; 3(6):538-42. PubMed ID: 17170038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation in long-term clinical trials.
    Hlatky MA; Boothroyd DB; Johnstone IM
    Stat Med; 2002 Oct; 21(19):2879-88. PubMed ID: 12325104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.
    Nelson CL; Sun JL; Tsiatis AA; Mark DB
    Stat Med; 2008 Nov; 27(26):5525-55. PubMed ID: 18613251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological design for economic evaluation in Public Access Defibrillation (PAD) trial.
    Nichol G; Wells GA; Kuntz K; Feeny D; Longstreth W; Mahoney B; Mann C; Lucas R; Henry M; Huszti E; Birnbaum A
    Am Heart J; 2005 Aug; 150(2):202-8. PubMed ID: 16086918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics.
    Farahani P; Levine M; Goeree R
    J Eval Clin Pract; 2006 Aug; 12(4):463-70. PubMed ID: 16907691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of early treatment for retinopathy of prematurity.
    Kamholz KL; Cole CH; Gray JE; Zupancic JA
    Pediatrics; 2009 Jan; 123(1):262-9. PubMed ID: 19117891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
    Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
    Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental cost effectiveness evaluation in clinical research.
    Krummenauer F; Landwehr I
    Eur J Med Res; 2005 Jan; 10(1):18-22. PubMed ID: 15737949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial.
    Weintraub WS; Barnett P; Chen S; Hartigan P; Casperson P; O'Rourke R; Boden WE; Lewis C; Veledar E; Becker E; Culler S; Kolm P; Mahoney EM; Dunbar SB; Deaton C; O'Brien B; Goeree R; Blackhouse G; Nease R; Spertus J; Kaufman S; Teo K
    Am Heart J; 2006 Jun; 151(6):1180-5. PubMed ID: 16781215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.
    Willan AR; O'Brien BJ
    Health Econ; 1996; 5(4):297-305. PubMed ID: 8880166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Economic evaluation of cardiology; background and application].
    van Hout BA; Goes ES; Grijseels EW; Quarles van Ufford MA
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2083-6. PubMed ID: 9856220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is proper methodology associated with the use of a clinically relevant outcome measure? The case of randomized clinical trials on medical treatment of open-angle glaucoma.
    Rossetti L; Marchetti I; Orzalesi N; Scorpiglione N; Liberati A
    Online J Curr Clin Trials; 1993 Nov; Doc No 100():[6512 words; 199 paragraphs]. PubMed ID: 8305993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance.
    Donaldson C; Hundley V; McIntosh E
    Health Econ; 1996; 5(3):267-9. PubMed ID: 8817300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression.
    Thomas KC; Nosyk B; Fisher CG; Dvorak M; Patchell RA; Regine WF; Loblaw A; Bansback N; Guh D; Sun H; Anis A
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1212-8. PubMed ID: 17145536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems in interpreting cost effectiveness in clinical trials. Experimental versus implementation costs.
    De Nino LA; Mulrow CD; Gerety MB; Averyt EC
    Online J Curr Clin Trials; 1993 Apr; Doc No 44():[4864 words; 42 paragraphs]. PubMed ID: 8306003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.